Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Colorado, Denver
With
Merck Sharp & Dohme LLC
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
community-dwelling adults with primary or secondary open-angle glaucoma, and
a current prescription for monotherapy topical glaucoma medication.
You may not be if
patient-reported inability to administer eye drops that cannot be addressed successfully through in-person instruction at the clinic,
cognitive impairment at a level that would in the judgment of the referring physician interfere with study participation,
referring physician's determination that glaucoma surgery is likely within the next 6 months,
any active medical, psychological, or substance use disorder that would in the referring physician's judgment significantly interfere with study participation (e.g., comorbid congestive heart failure (CHF) resulting in a recent hospitalization; active psychosis due to uncontrolled bipolar disorder; etc.), or
no visual field test within the past 6 months (data required for the randomization approach described below).
Clareo Health | RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence
